Five SNPs detected in CCL5, CCR5 and CCR7 were significantly associated with prostate cancer risk among all study participants; however, only three markers survived adjustments for potential confounders and multiple hypothesis testing. This evidence concerns the gene CCL5 and prostate carcinoma.